SENS-AI
BLU Trading Statement Neutral

BLU LABEL UNLIMITED GROUP LIMITED - Trading statement for the year ended 31 May 2026

Blu Label Unlimited Group Limited
Full analysis

What this filing means

BLU reports HEPS down 81%–83% and Core HEPS down 80%–82% for the year to May 2026, driven by Cell C restructuring accounting effects — as flagged at the interim stage. But the ex-Cell C Core HEPS of 75.33 cents versus the prior year's 461.63 cents is an 84% earnings decline, exposing severe underlying business deterioration that the Cell C narrative does not fully explain. No cash flow, debt or segment detail is provided, leaving investors unable to assess quality or recurrence risk.

Blu Label is reporting that its earnings per share collapsed — not just because of a one-off accounting hit from restructuring Cell C, but because the underlying business itself is earning far less than it did a year ago. The company says its ex-Cell C operations produced Core HEPS of 75.33 cents, but last year it earned 461.63 cents per share. That gap is not a rounding error. Investors cannot yet see the cash flow or debt picture to judge whether this is a temporary hit or something structural.

Bull case

  • Underlying ex-Cell C operations delivered R9.4bn revenue, R923m EBITDA, R677m net profit after tax and Core HEPS of 75.33c, showing the core distribution business remains solidly profitable.
  • Distribution platforms processed R99.9bn in imputed gross revenue across PINless top-ups, prepaid electricity, ticketing and universal vouchers, underscoring substantial transactional scale.
  • Rebrand to Blu Label Unlimited Group reframes the identity around the standalone distribution franchise, distancing the equity story from the Cell C accounting overhang.

Bear case

  • Underlying Core HEPS of 75.33c vs 461.63c prior year is an ~84% drop — stripping out Cell C noise barely changes the picture, exposing a severe operational decline.
  • EPS swung from a 276.52c profit to a 542.50c–536.96c loss, a >100% decline that erased reported earnings and likely equity value per share.
  • Financial information is unaudited and no cash flow, debt or segment breakdown is provided — investors cannot assess whether the Cell C impairment is truly non-recurring or whether further write-downs are likely.
  • R99.9bn imputed gross flows produced only R2.555bn gross income and R923m EBITDA — a thin-margin distribution model where any revenue compression would magnify the earnings fall.
  • Risk: Prior-period comparative (FY2025) itself 'materially impacted' by same Cell C restructuring, per filing. This means the 81%-83% HEPS decline is not a clean operating trend but partly reflects accounting recognition timing differences between periods. The underlying business ex-Cell C generated R677m net profit and R923m EBITDA.
View original SENS announcement

AI-generated summary by SENS-AI, based on the original JSE SENS filing.

SENS-AI conclusion

The Cell C restructuring is a genuine and disclosed headwind, but it is not the whole story. Stripping it out leaves ex-Cell C Core HEPS of 75.33 cents against a prior-year base of 461.63 cents — a structural earnings compression of roughly 84% that the Cell C narrative does not explain away. The rebrand to Blu Label Unlimited Group is intended to distance the equity from that overhang, but it does not restore the earnings base. The open questions — cash conversion, leverage, segment mix — will define whether the 75.33 cent underlying base is defensible or at further risk. So what: the earnings story has deteriorated materially, and the audited accounts in August will be the market's first real test of whether the distribution franchise can recover, or whether the underlying business decline is structural. Missing evidence: No cash-flow or balance-sheet data — full results required; No segmental revenue or profit breakdown for core operations; Unaudited numbers subject to change on audit; Prior-period comparative itself distorted by same Cell C items — base effect unreliable; No forward guidance or outlook statement provided; Core HEPS 75.33c is a hypothetical pro forma, not a reported GAAP metric

The August 2026 audited results are where the market will test whether the R677 million ex-Cell C net profit and R923m EBITDA are cash-generative and durable, and whether any further impairments or Cell C-linked write-downs remain.

Evidence from the filing

  • Underlying ex-Cell C operations delivered R9.4bn revenue, R923m EBITDA, R677m net profit after tax and Core HEPS of 75.33c, showing the core distribution business remains solidly profitable.

    “Excluding Cell C Holdings Limited ("Cell C") and Comm Equipment Company's financial results, all extraneous items relating to the restructuring transactions and listing of Cell C, loss on disposals and impairments, BLU would have reported revenue of R9.4 billion, gross income of R2.555 billion, EBITDA of R923 million and net profit after tax of R677 million. Core headline earnings would have totalled R681 million, equating to Core HEPS of 75.33 cents”

  • Distribution platforms processed R99.9bn in imputed gross revenue across PINless top-ups, prepaid electricity, ticketing and universal vouchers, underscoring substantial transactional scale.

    “the imputed gross revenue generated from these sources amounted to R99.9 billion”

  • Rebrand to Blu Label Unlimited Group reframes the identity around the standalone distribution franchise, distancing the equity story from the Cell C accounting overhang.

    “Previously Blue Label Telecoms Limited”

  • EPS swung from a 276.52c profit to a 542.50c–536.96c loss, a >100% decline that erased reported earnings and likely equity value per share.

    “Earnings per share — May 2025: 276.52 cents per share; May 2026: (542.50) – (536.96) cents per share; Percentage Decrease: > (100%)”

  • Financial information is unaudited and no cash flow, debt or segment breakdown is provided — investors cannot assess whether the Cell C impairment is truly non-recurring or whether further write-downs are likely.

    “The financial information on which this trading statement is based has not been reviewed or audited by the Company's external auditors”

  • Reported HEPS top of 88.14c sits only ~12.8c above the ex-Cell C Core HEPS of 75.33c, undermining the framing that Cell C restructuring is the principal driver of the decline.

    “Headline earnings per share — May 2025: 455.96 cents per share; May 2026: 79.02 – 88.14 cents per share; Percentage Decrease: (83%) – (81%)”
Category
Trading Statement
Event posture
No Edge
Published
Aug 14, 2026

More on Blu Label Unlimited Group Limited

Blu Label Unlimited Group Limited (BLU) share price All Blu Label Unlimited Group Limited SENS announcements

Related filings